A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Clinical trial NCT06179160 · RECRUITING
Trial details
- NCT number
- NCT06179160
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2027-01-01
- Enrollment
- 710
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.